Table 3.
Group | Control | Daidzein Short | Daidzein Long |
---|---|---|---|
Osteocalcin (ng/ml) | |||
Male | |||
PND 22 | 1.91 ± 0.12a | 1.48 ± 0.08b | 1.51 ± 0.08b |
PND 35 | 4.08 ± 0.22ab | 3.34 ± 0.30b | 4.45 ± 0.20a |
PND 77 |
5.04 ± 0.33 |
4.23 ± 0.17 |
4.84 ± 0.22 |
Female | |||
PND 22 | 1.64 ± 0.04 | 1.62 ± 0.06 | 1.63 ± 0.05 |
PND 35 | 3.95 ± 0.10a | 3.37 ± 0.09b | 3.67 ± 0.06ab |
PND 77 | 4.23 ± 0.11 | 4.16 ± 0.14 | 4.11 ± 0.13 |
All values are means ± SE (n = 6). Values that do not share the same superscript letters are significantly different from each other (p < 0.05). Data were analyzed using one-way ANOVA. Differences between the groups were assessed by Tukey's test.
Control; the group fed the control diet, Daidzein Short; the group fed the daidzein diet (0.5 g daidzein/kg diet) during both pregnancy and lactation periods, Daidzein Long; the group fed the daidzein diet (0.5 g daidzein/kg diet) during pregnancy, lactation and postweaning periods.
PND: postnatal day.